Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines - WSJ
Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines WSJ
Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines WSJ
With 50 Days to the Midterms, It All Might Come Down to One Thing WSJ
Altman Says AI’s Rapid Progress Could Go ‘Very Badly’ WSJ
The Morning Risk Report: Congress Is Suddenly Waking Up to the AI Doomsday Threat WSJ
Exclusive | Airbnb Sets Up $250 Million Fund to Invest in Housing Construction WSJ
U.S. Treasury Yields Edge Lower, German 10-Year Bund Yield Hits New 15-Year High WSJ
The Escalating Effort to Slow AI WSJ
Chip Stocks Tumble After AI Leaders Call For Slowdown in AI Development WSJ
Stocks Have the Midterm Blues WSJ
Oil Prices Rise as Saudi East-West Pipeline Attack Threatens Export Routes WSJ
Did a Crypto Bro Pay $4.5 Million to Marry a Movie Star? A Scandal Grips China WSJ
Forget Robot Workers, This Company Wants to Build Soldiers WSJ
Oil Jumps, Nasdaq Futures Slide as AI-Related Stocks Tumble Worldwide WSJ
Dollar Rises on Fed Rate-Hike Prospects, High Oil Prices WSJ
Metlen Signs Greek Energy Supply Deal with Petronas wsj.com
AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial WSJ
Opinion | The ICJ’s Pernicious Plan to Redefine Genocide WSJ
Wisconsin Governor Candidate Swims to Safety After Plane Ditches in Lake WSJ